U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07899502) titled 'REAL-MS: Observational Database Study of AHSCT and MS Therapies' on Oct. 12.
Brief Summary: Multiple sclerosis (MS) is a condition in which the immune system damages the brain and spinal cord. Treatments called disease-modifying therapies can reduce inflammation and disease activity. For some people with highly active MS, autologous haematopoietic stem cell transplantation (AHSCT) may be used. AHSCT uses a person's own blood-forming stem cells after treatment that suppresses the immune system.
REAL-MS is an observational study that will collect and analyse information from routine clinical care to compare the longer-term effectiven...